Receptor Tyrosine Kinase

Receptor tyrosine kinases (RTKs) are cell-surface proteins that detect extracellular signals and convert them into intracellular instructions controlling growth, survival, differentiation, and metabolism. When a ligand binds an RTK, the receptor typically dimerizes, bringing its intracellular kinase domains together so they can phosphorylate tyrosine residues on one another and create docking sites for signaling proteins. These interactions activate pathways such as RAS-MAPK and PI3K-AKT, linking cellular communication to changes in gene expression and behavior. RTKs are central to developmental and cancer biology, and their abnormal activation has made them important targets for diagnostic research and kinase-inhibitor therapies.

Receptor Tyrosine Kinase - Related Videos

Education

JoVE Core - Cell Biology

Receptor Tyrosine Kinases

0 Views •

2025

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Research

JoVE Journal - Medicine

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

0 Views •

Cited by 6 •

2013

Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

0 Views •

2024

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath. TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Protein Kinases and Phosphatases

0 Views •

2020

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven. Protein kinases Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

0 Views •

Cited by 1 •

2018

Here, we present a protocol for antibody arrays to identify alterations in signaling pathways in various cellular models. These changes, caused by drugs/hypoxia/ultra-violet light/radiation, or by overexpression/downregulation/knockouts, are important for various disease models and can indicate whether a therapy will be effective or can identify mechanisms of drugs resistance.

View All Results

FAQs

Related Topics